MRNA — All updates

MRNA — 5 entries on this page, 0 of them a change of direction.

Filter this page

Brian ShannonPublished 2026-09-11

“Stock Market, Bitcoin, Gold Analysis for Week Ending 9/11/26”

$MRNANo side taken

MRNA remains choppy; buyers not yet in control, but potential for renewed leadership if range tightens.

we know uh the genomics stocks kind of lit this group on fire a couple weeks ago with the mRNA move and mRNA has really just been you know very choppy. If we put an anchor on the event it provides zero value basically the fiveday moving average is rising in here.

So, I think that, you know, you look at it and say we found buyers along the 20-day moving average. Maybe an inside day on Monday, tighten the range, and then uh MRNA might be able to uh establish some leadership once again, but it's still a little bit too early uh to say that the buyers are gaining control in there.

Watch the source04:13

Older record

Brian ShannonPublished 2026-09-08

“Brian Shannon Trader TV Live 9/8/26”

$MRNANo side taken

MRNA is poised for a significant move (powder keg) that should resolve soon.

Good point about mRNA being the driver, because that stock feels like a powder keg about to explode. That's it. Hopefully, it happens soon and settles the matter. I mean, I think Moderna has something going for it, Moderna really set that in motion, and you were 100% right about that.

Watch the source12:01

Older record

BenzingaPublished 2026-08-31

“$SPY, $QQQ Slide as US-Iran Tensions Flare | PreMarket Playbook | August 31, 2026”

$MRNANo side taken

MRNA must hold 130/120 support to maintain upside potential; failure risks a significant gap fill.

And speaking of healthcare, Stefan was asking earlier about Madna, which obviously had the huge cancer vaccine news. Here's a look at the chart 13. I know we're running out of time, but to me, this really kind of needs to hold 130.

1301 120. If it holds these two areas, we still have room in this God candle that we're still inside to the upside. But if we end up coughing this up, I think we are looking at a nasty gap fill below.

Watch the source1:34:25

Older record

Meet KevinPublished 2026-08-24

“Memory Stock Crash, Bessent Bailout, Iran, Stocks & Real Estate”

$MRNANo side taken

MRNA is in a post-enthusiasm pullback; uncertain stabilization, company unprofitable but cancer therapy is a first-stage opportunity; AI catalyst may be limited if frontier models aren't needed.

So then uh you've got Mona coming down again a little bit here. another 8%. There is a lot of trading volume in this. So, it's not uncommon to see some of this juice come out. This is a very very normal kind of post enthusiasm bleed out.

Uh, and I'm very curious to see if it stabilizes at 126 or if it keeps going down. Uh, could be some opportunities there. Obviously, the company still loses money, but massive hope and it's not really a cancer vaccine.

I know people call it a cancer vaccine, but it's more of um a cancer therapy that they're working on, which which is also very important. Um in fact, um I mean, while a vaccine would be cool, I think this is more of a first stage.

Watch the source17:44

Older record

Brian ShannonPublished 2026-08-21

“Stock Market & Crypto Analysis for Week Ending 8/21/26”

$MRNABullish

MRNA is performing as hoped, consolidating gains after major news, and has sparked strength in the sector.

The big news was mRNA. I'm not going to repeat news to you, but this is you know, the stock is doing what I was hoping it would. Here's the anchor from the event. So, it's just absorbing the strength, digesting the gains for now, but it's lit this group on fire.

Watch the source10:58

Older record

That's the earliest record

All updates for other tickers

$META $NVDA $AMD $MU $AAPL $TSLA $GOOGL $ORCL $ADBE $AVGO $AMZN $NFLX See all tickers

Follow $MRNA30-day free trial

Start trial